Investigative Ophthalmology & Visual Science Cover Image for Volume 62, Issue 8
June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Comparing Hypertropia (HT) in Upgaze and Downgaze Does Not Distinguish Congenital From Acquired Superior Oblique Palsy (SOP)
Author Affiliations & Notes
  • Joseph L Demer
    Ophthalmology, University of California Los Angeles, University of California Los Angeles, Los Angeles, CA, US, academic, Los Angeles, California, United States
    Neurology, University of California Los Angeles, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Joseph Demer, None
  • Footnotes
    Support  NIH Grant EY008313
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2603. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joseph L Demer; Comparing Hypertropia (HT) in Upgaze and Downgaze Does Not Distinguish Congenital From Acquired Superior Oblique Palsy (SOP). Invest. Ophthalmol. Vis. Sci. 2021;62(8):2603.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Ivanir & Trobe claimed that HT greater in up than downgaze, or equal to it, is characteristic of decompensated congenital & never present in ischemic, traumatic, or tumorous SOP (J. Neuro-Ophthalmol. 37:2017). This claim was tested in SOP confirmed by MRI demonstration of subnormal superior oblique (SO) size.

Methods : Quasi-coronal, surface coil MRI was performed in target-controlled central gaze to identify patients with unilateral SO hypoplasia indicative of SOP. Nine subjects had unequivocal congenital onset (mean age 38±16 yrs, standard deviation, SD); 7 subjects had unequivocal acquired onset (age 47±14 yrs, symptom duration 5.4±4.8 yrs), including 2 with trochlear Schwannoma and 5 with severe head trauma; and 15 subjects had progressive onset unequivocally not congenital (age 52±19 yrs, symptom duration 13±14 yrs).

Results : Results: Maximum SO cross section averaged 8.6±3.9mm2 in congenital & 11.3±3.5mm2 in acquired SOP (P=0.08), significantly less than 19mm2 identically in both groups contralesionally (P<10-4). Although mean central gaze HT was greater at 20.6±8.0Δ in 9 cases of congenital than 22 acquired cases at 11.4±6.8Δ (P=0.002), HT was 8.4±16.3Δ less in up than down gaze in congenital SOP, and 3.7±11.2Δ less in acquired SOP. In congenital SOP, 33% of subjects had HT greater in up than downgaze, while in 67% HT was greater in down gaze (by up to 42D). In acquired SOP, HT was greater in up than downgaze, or equal to it in 8 cases (36%, P=0.87, X2); the similar proportions contradict Ivanir & Trobe’s claim. In acquired SOP, HT was greater in up than down gaze in 37%, & greater in down than up gaze in 59% of cases. HT was equal in up & central gazes in 3 acquired and no congenital SOP cases. Trends were similar in unequivocal acquired & progressive acquired (non-congenital) SOP (P>0.4).

Conclusions : HT is not characteristically greater in up than down gaze in congenital SOP proven by SO atrophy on MRI. In fact, average HT is greater in down than up gaze in both acquired & congenital SOP, sometimes strikingly so in the latter. The finding of HT greater in up than downgaze, or equal to it, does not reliably indicate that SOP is congenital.

This is a 2021 ARVO Annual Meeting abstract.

 

T1 contrast MRI of right SO hypoplasia:
Top. 41 yr old man with left head tilt since birth. HT greater down than up, fuses 50D vertically.
Bottom. 27 year old man symptomatic for 14 yrs post trauma. HT greater up than down.

T1 contrast MRI of right SO hypoplasia:
Top. 41 yr old man with left head tilt since birth. HT greater down than up, fuses 50D vertically.
Bottom. 27 year old man symptomatic for 14 yrs post trauma. HT greater up than down.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×